Date of Decision: September 27, 2024
Service Center: Texas Service Center
Form Type: Form I-140
Case Type: EB-1 Extraordinary Ability
Petitioner Information
Profession: Biomedical Research Scientist
Field: Biomedical Sciences
Nationality: Not specified in the document
Summary of Decision
Initial Decision: Denied
Appeal Outcome: Dismissed
Evidentiary Criteria Analysis
The petitioner sought to meet at least three of the ten regulatory criteria under 8 C.F.R. § 204.5(h)(3) but satisfied only one. The Administrative Appeals Office (AAO) concluded that the evidence did not meet the standard of sustained national or international acclaim or recognition required for EB-1 classification.
Criteria Met:
- Authorship of Scholarly Articles:
- The petitioner provided evidence of publishing research in reputable journals such as The Journal of Allergy and Clinical Immunology and PLOS One.
Criteria Not Met:
- Lesser Nationally or Internationally Recognized Prizes or Awards:
- The petitioner presented evidence of receiving a poster presentation award at the 2015 EAACI Annual Congress. However, the evidence lacked details about the award’s national or international significance, its criteria, or its exclusivity.
- Original Contributions of Major Significance:
- The petitioner provided letters of recommendation and citation records but failed to demonstrate that her research contributions were widely recognized as major advancements in the biomedical field.
- Published Material About the Petitioner:
- The petitioner did not address the Director’s finding that no published material about her work met the regulatory requirements.
Key Points from the Decision
Awards Evidence:
- The AAO found insufficient evidence to demonstrate that the petitioner’s poster presentation award was nationally or internationally recognized for excellence in biomedical sciences.
Contribution Significance:
- The petitioner’s research was acknowledged but lacked evidence of widespread adoption or field-wide impact to establish major significance.
Citation Record:
- The petitioner’s articles received 52 cumulative citations, but there was no comparative data to demonstrate that this level of citation was indicative of major significance in the field.
Recommendation Letters:
- Letters from colleagues praised the petitioner’s originality and research contributions but lacked sufficient detail or corroborative evidence of significant field-wide impact.
Supporting Documentation
Authorship Evidence: Publications in peer-reviewed journals, including The Journal of Allergy and Clinical Immunology and PLOS One.
Award Evidence: Documentation of a poster presentation award at the 2015 EAACI Annual Congress, deemed insufficient for meeting the criterion.
Contribution Evidence: Letters of recommendation and citation data, not adequately demonstrating major significance.
Conclusion
Final Determination: The appeal was dismissed.
Reasoning:
The petitioner met one regulatory criterion under 8 C.F.R. § 204.5(h)(3). However, the evidence failed to demonstrate sustained national or international acclaim or recognition as one of the small percentage at the very top of the field of biomedical sciences.
